Research Article

Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson’s Disease

Table 1

Demographic and clinical characteristics of the study participants.

VariablePD patients (n = 275)Healthy controls (n = 149) value

Age, years60.96 ± 10.0260.23 ± 11.450.750
Sex, Male %64.765.10.939
PD duration6.65 ± 6.38
Hoehn and Yahr stage1.54 ± 0.51
MDS-UPDRS Part III20.16 ± 9.03
RBDSQ3.85 ± 2.532.78 ± 2.29<0.001
GDS-151.97 ± 2.291.12 ± 2.06<0.001
STAI State31.39 ± 8.8327.28 ± 7.78<0.001
STAI Trait30.91 ± 8.4628.46 ± 7.170.002
ESS5.78 ± 3.525.63 ± 3.470.745
MoCA27.18 ± 2.3228.28 ± 1.10<0.001
UPSIT22.75 ± 8.1734.20 ± 5.04<0.001
Storage symptoms (total)3.02 ± 2.052.28 ± 1.46<0.001
Urgency0.40 ± 0.660.12 ± 0.33<0.001
Urinary incontinence0.27 ± 0.520.07 ± 0.25<0.001
Frequency1.05 ± 0.820.85 ± 0.690.019
Nocturia1.31 ± 0.871.23 ± 0.840.469
Voiding symptoms (total)0.87 ± 1.060.57 ± 0.890.002
Incomplete emptying0.42 ± 0.630.27 ± 0.540.007
Weak stream of urine0.44 ± 0.660.30 ± 0.540.027